< Back to scientific publications

Magazine 11.26

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAracetam add-on First Italian‚oRk Study (BRIVAFIRST) Group.

Date: 2022

Scope of interest: Epilepsy




You may also be interested in:

Magazine 2,646

Impact of home patient telemonitoring on use of β-blockers in congestive heart failure.

Authors: Antonicelli R, Mazzanti I, Abbatecola AM, Parati G

Date: 2010

Scope of interest: pharmacology, ageing


Read details
Magazine 3,445

Cu to Zn ratio, physical function, disability, and mortality risk in the elderly (the SIRENTE study).

Authors: Mocchegiani E, Malavolta M, Lattanzio F, Piacenza F, Basso A, Abbatecola AM, Russo A, Giovannini S, Capoluongo E, Bustacchini S, Guffanti EE, Bernabei R, Landi F

Date: 2012

Scope of interest: gerontology, geriatrics


Read details
Magazine 17,152

Diabetes Affects Antibody Response to SARS-CoV-2 Vaccination in Older Residents of Long-Term Care Facilities: Data From the GeroCovid VAX Study.

Authors: Virgilio E, Trevisan C, Abbatecola A, Malara A, Palmieri A, Fedele G, Stefanelli P, Leone P, Schiavoni I, Maggi S, Volpato S, Antonelli Incalzi R, Onder G; GeroCovid Vax Working Group; GeroCovid Vax Working Group.

Date: 2022

Scope of interest: diabetes


Read details